Clinical Trial Update: 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of a 9-cis beta-carotene-rich extract from Dunaliella algae in retinitis pigmentosa is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga (9-cis beta-carotene-rich extract from Dunaliella algae)

Snippet

Sponsor: Sheba Medical Center | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING